Despite the precise role of Nrf2 in ALS pathogenesis remaining unclear, accumulating evidence suggests that Nrf2 plays a pivotal role, and its activity may serve as a novel therapeutic target [22]. Here, NFE2L2 is linked to amyotrophic lateral sclerosis.